These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4169787)

  • 1. Failure of endogenous stimulation of secretin and pancreozymin release to influence serum-insulin.
    Mahler RJ; Weisberg H
    Lancet; 1968 Mar; 1(7540):448-51. PubMed ID: 4169787
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.
    Dupre J; Curtis JD; Unger RH; Waddell RW; Beck JC
    J Clin Invest; 1969 Apr; 48(4):745-57. PubMed ID: 5774112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gastrointestinal stimulus to insulin release. I. Secretin.
    Chisholm DJ; Young JD; Lazarus L
    J Clin Invest; 1969 Aug; 48(8):1453-60. PubMed ID: 5796357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood sugar and plasma insulin response to stimulation of endogenous secretin release].
    Kaess H; Schlierf G
    Diabetologia; 1969 Aug; 5(4):228-32. PubMed ID: 4902719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of secretin and pancreozymin on serum insulin and glucose levels].
    Kopyłow A; Kaszuba Z; Stachowski A; Marlicz K
    Pol Arch Med Wewn; 1979 Feb; 61(2):127-34. PubMed ID: 440979
    [No Abstract]   [Full Text] [Related]  

  • 6. Extra-gastrointestinal effects of secretin, gastrin, and pancreozymin.
    Lazarus NR; Voyles NR; Devrim S; Tanese T; Recant L
    Lancet; 1968 Aug; 2(7562):248-50. PubMed ID: 4173685
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.
    Boden G; Essa N; Owen OE; Reichle FA
    J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of secretin and cholecystokinin-pancreozymin on the stomach].
    Duffaut M; Tournut R; Ribet A
    Biol Gastroenterol (Paris); 1971; 3():Suppl 3:237-52. PubMed ID: 4942306
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between changes of serum cholecystokinin-pancreozymin and serum insulin after different stimuli.
    Grayburn JA; Harvey RF; Jennings RD; Dowsett L; Hartog M
    Diabetologia; 1975 Feb; 11(1):35-8. PubMed ID: 1140517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological doses of secretin do not stimulate acute insulin release.
    Brodows RG; Chey WY
    J Clin Endocrinol Metab; 1980 Mar; 50(3):603-6. PubMed ID: 6987259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intraduodenal perfusions of hydrochloric acid and insulin secretion in man].
    Mainguet P; Ooms HA; Franckson JR
    C R Seances Soc Biol Fil; 1970; 164(3):680-4. PubMed ID: 4250432
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in insulin, growth hormone and pancreatic enzyme secretion after intravenous and intraduodenal administration of mixed amino acids in man.
    Raptis S; Dollinger HC; Schröder KE; Schleyer M; Rothenbuchner G; Pfeiffer EF
    N Engl J Med; 1973 Jun; 288(23):1199-202. PubMed ID: 4700552
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of aminophylline on insulin release induced by secretin and cholecystokinin-pancreozymin in normal humans.
    Serrano-Ríos M; Hawkins FG; Escobar-Jiménez F; Rodriguez-Miñón JL
    J Clin Endocrinol Metab; 1974 Feb; 38(2):194-9. PubMed ID: 4812615
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.
    Ebert R; Illmer K; Creutzfeldt W
    Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.
    Unger RH; Ketterer H; Dupré J; Eisentraut AM
    J Clin Invest; 1967 Apr; 46(4):630-45. PubMed ID: 4290022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma insulin concentration during physiological variations in immunoreactive plasma secretin.
    de Muckadell OB; Fahrenkrug J; Kühl C
    Horm Metab Res; 1976 Jul; 8(4):253-6. PubMed ID: 8364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gastrointestinal stimulus to insulin release. II. A dual action of secretin.
    Kraegen EW; Chisholm DJ; Young JD; Lazarus L
    J Clin Invest; 1970 Mar; 49(3):524-9. PubMed ID: 5415678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of vagal stimulation and duodenal acidification in the regulation of pancreatic secretion].
    Mei MH; Chen Q
    Sheng Li Xue Bao; 1985 Oct; 37(5):410-5. PubMed ID: 3837339
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulinotropic and possible insulin-like effects of secretin and cholecystokinin-pancreozymin.
    Glick Z; Baile CA; Mayer J
    Endocrinology; 1970 Apr; 86(4):927-31. PubMed ID: 4984006
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiology and physiopathology of gastrointestinal hormones of the gastrin and secretin group. II. The cholecystokinin-pancreozymin and secretin group].
    Hausamen TU; Fritsch WP
    Z Gastroenterol; 1977 May; 15(5):320-36. PubMed ID: 327711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.